中石化煉化(02386.HK)去年簽訂合同總值523.2億人幣 按年增2.7%
中石化煉化工程(02386.HK)公布,截至去年12月31日止十二個月期間,集團新簽訂合同總值為523.19億元人民幣(下同),按年增加2.7%。於去年12月31日,集團未完成合同量為949.93億元,按年增加0.1%。另外,去年第四季集團新簽訂的合同總值為115.06億元,代表性合同包括與中石化鎮海煉化分公司簽訂了1,500萬噸/年煉油120萬噸/年乙烯擴建項目之80萬噸/年乙二醇裝置EPC總承包合同,合同金額總計約為11.27億元;與浙江石油化工簽訂了舟山煉化一體化項目二期之芳烴裝置施工合同,合同金額總計約為12.75億元;及與沙特阿拉伯國家石油公司簽訂了Marjan油氣增產擴建項目施工合同,合同金額總計約為1.44億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.